Andriany Qanitha | cardiovascular | Best Researcher Award

Published on by Popular Engineer

Assoc. Prof. Dr. Andriany Qanitha | Cardiovascular | Best Researcher Award

MD, FIHA, M.Sc, Ph.D at Faculty of Medicine, Hasanuddin University, Indonesia

Dr. Andriany Qanitha is an accomplished cardiovascular researcher and Associate Professor at Hasanuddin University with a strong academic background, including a Ph.D. from the University of Amsterdam and multiple cum laude honors. Her research focuses on coronary artery disease and cardiovascular care in low-resource settings, leading to impactful publications in high-ranking journals such as BMJ Open and Scientific Reports. She has received several international accolades, including the  Global Heart Journal Best Paper Award and prestigious grants from the European Society of Cardiology and Erasmus+. Dr. Qanitha plays a leadership role as Head of the Clinical Epidemiology, Research, and Publication Unit and serves on editorial boards of renowned journals. Her involvement in international collaborations and professional societies reflects her global influence. With a proven track record in public health innovation, telemedicine, and education, she is a highly suitable and deserving candidate for the Best Researcher Award.

Professional Profile

Google Scholar | Scopus Profile | ORCID Profile 

Education

Dr. Andriany Qanitha has pursued an exceptional academic path marked by consistent excellence. She began her education in Makassar, Indonesia, attending SD Inpres Pannara, SMP Negeri, and SMU Negeri. She earned her Bachelor of Medicine and completed her Medical Doctor (MD) professional program at the Faculty of Medicine, Hasanuddin University, graduating with cum laude honors. She then advanced her studies internationally, earning a Master of Science (M.Sc) degree from University Medical Center Utrecht, the Netherlands. Dr. Qanitha further attained her Ph.D. from the Academic Medical Center, University of Amsterdam, with a strong research focus on cardiovascular health in resource-poor settings. Currently, she is pursuing her specialist training in Cardiology and Vascular Medicine (FIHA) at Hasanuddin University. Her academic journey reflects a blend of national excellence and international research exposure, equipping her with comprehensive clinical, academic, and scientific expertise.

Experience

Dr. Andriany Qanitha’s professional experience spans clinical practice, academic teaching, and international research collaboration. She began her career as a licensed General Physician, serving in various emergency departments and clinics in Makassar, Indonesia, including Fatimah Mother and Child Hospital and RS Ibnu Sina. Transitioning to academia, she joined the Faculty of Medicine at Hasanuddin University, where she has served in multiple roles, including lecturer in the Medical Education Unit, Department of Physiology, and Department of Biomedicine. She also teaches in the Doctoral Study Program, contributing to postgraduate medical education. Her leadership as Head of the Clinical Epidemiology, Research, and Publication Unit highlights her commitment to advancing medical research and evidence-based practice. Dr. Qanitha has also managed international projects such as Erasmus+ HEALTH-I and is actively engaged in global health research. Her diverse professional background reflects a blend of clinical service, academic excellence, and international collaboration in cardiovascular medicine.

Research Interest

Dr. Andriany Qanitha’s research interests center on cardiovascular diseases, particularly coronary artery disease, within resource-limited settings. She is deeply committed to improving clinical outcomes and healthcare access for underserved populations through evidence-based interventions. Her work explores the epidemiology, risk factors, and management strategies for cardiovascular conditions, with a strong focus on real-world data from Southeast Asia. She is also actively involved in studying the impact of early-life infections, pregnancy-related conditions, and adherence to clinical guidelines on long-term cardiac health. In addition, Dr. Qanitha integrates digital health innovations—such as telemedicine and mobile health education—into her research, aiming to enhance public health delivery. Her interdisciplinary approach bridges clinical cardiology, epidemiology, and health systems research. Through international collaborations and participation in global consortia, she contributes to shaping cardiovascular care policies and practices in low- and middle-income countries. Her research is both regionally impactful and globally relevant, addressing critical gaps in global cardiovascular health.

Award and Honor

Dr. Andriany Qanitha has received numerous prestigious awards and honors in recognition of her academic excellence, research achievements, and international contributions to cardiovascular medicine. She was named the Best Graduate of the Medical Doctor program at Hasanuddin University and awarded the DIKTI Scholarship by Indonesia’s Ministry of National Education. Internationally, she received the European Society of Cardiology (ESC) Educational Grant and the European Association for International Education (EAIE) Grant. She has also been recognized with the Global Heart Journal Best Paper Award in 2024 by the World Heart Federation. Additionally, Dr. Qanitha was the second-place winner of the BPJS National Research Grant and was appointed as the EAPC Young Ambassador for Indonesia. Her leadership roles include serving as Project Manager for the Erasmus+ HEALTH-I initiative and as Head of the Clinical Epidemiology, Research, and Publication Unit at Hasanuddin University. These accolades reflect her global impact and dedication to advancing cardiovascular research and education.

Research Skill

Dr. Andriany Qanitha possesses a diverse and advanced set of research skills that span clinical epidemiology, cardiovascular medicine, health systems analysis, and digital health innovation. She is highly skilled in designing and conducting both observational and interventional studies, with a focus on coronary artery disease in low-resource settings. Her expertise includes advanced statistical analysis, data interpretation, and scientific writing, demonstrated through her numerous peer-reviewed publications in high-impact journals. She is proficient in utilizing digital tools for telemedicine research and has contributed to tele-education initiatives aimed at improving patient outcomes. Dr. Qanitha also excels in grant writing and project management, having led international collaborations such as the Erasmus+ HEALTH-I program. Her role on editorial boards and as a reviewer further reflects her critical thinking, peer evaluation, and academic rigor. Her ability to translate complex research findings into actionable healthcare solutions highlights her as a skilled and impactful medical researcher.

Publications Top Notes

Title: Cigarette smoke exposure and stunting among under-five children in rural and poor families in Indonesia
Authors: N. Muchlis, R.A. Yusuf, A.R. Rusydi, N.U. Mahmud, N. Hikmah, A. Qanitha, …
Year: 2023

Title: Clinical cardiology in South East Asia: Indonesian lessons from the present towards improvement
Authors: A. Qanitha, N. Qalby, M. Amir, C.S.P.M. Uiterwaal, J.P.S. Henriques, …
Year: 2022

Title: The readiness of public primary health care (PUSKESMAS) for cardiovascular services in Makasar city, Indonesia
Authors: D.S. Arsyad, E.F. Hamsyah, N. Qalby, A. Qanitha, J. Westerink, M.J. Cramer, …
Year: 2022

Title: Infections in early life and premature acute coronary syndrome: a case-control study
Authors: A. Qanitha, B.A.J.M. de Mol, D.R. Pabittei, I. Mappangara, Y. van der Graaf, …
Year: 2016

Title: Predictors of medium-term mortality in patients hospitalised with coronary artery disease in a resource-limited South-East Asian setting
Authors: A. Qanitha, C.S.P.M. Uiterwaal, J.P.S. Henriques, I. Mappangara, I. Idris, M. Amir, …
Year: 2018

Title: Exploring the link between cardiovascular risk factors and manifestations in latent tuberculosis infection: a comprehensive literature review
Authors: A.Q. Irawaty Djaharuddin, Muzakkir Amir
Year: 2023

Conclusion

Dr. Andriany Qanitha is a highly accomplished and globally engaged cardiovascular researcher whose work has had a demonstrable impact on both science and public health, particularly in resource-limited settings. Her strong academic record, international collaborations, and award-winning research output position her as an exceptional candidate for the Best Researcher Award.

Wijdan Al-Ahmadi | Biomedicine | Best Researcher Award

Published on by Popular EngineerLeave a Comment on Wijdan Al-Ahmadi | Biomedicine | Best Researcher Award

Dr. Wijdan Al-Ahmadi | Biomedicine | Best Researcher Award

Associate scientest, King Faisal specialist hospital and research center, Saudi Arabia

Dr. Wijdan Al-Ahmadi is a seasoned researcher with over 20 years of experience in biomedicine, focusing on cancer biology, immunology, and disease mechanisms. Based in Riyadh, Saudi Arabia, she is a key member of the Molecular Biomedicine Research Department at King Faisal Specialist Hospital and Research Center. Her work spans diverse fields, including inflammatory diseases and cardiovascular research. Notably, in 2023, she contributed to a groundbreaking experiment aboard the International Space Station (ISS), highlighting her ability to conduct research in extreme environments. Dr. Al-Ahmadi has demonstrated leadership through her work as an educator, mentoring students at various academic levels. Her contributions continue to push the boundaries of biomedicine, paving the way for new therapeutic strategies and personalized medicine approaches.

Profile

Education

Dr. Wijdan Al-Ahmadi holds a Ph.D. in Bioscience from Cardiff University (2015–2019), where she focused on cancer and immunology research. She also earned a B.Sc. in Biochemistry from King Saud University (1994–1998). Her academic journey has equipped her with advanced expertise in molecular biology, cancer research, and biomedical sciences. Dr. Al-Ahmadi’s educational foundation is complemented by her extensive hands-on experience in laboratory settings, which has enabled her to contribute to numerous pioneering studies. Through her formal education and continuous professional development, she has maintained a passion for unraveling disease mechanisms and enhancing health outcomes through scientific innovation.

Experience

Dr. Al-Ahmadi’s career spans over two decades in the field of biomedicine. She currently serves as an Associate Scientist at King Faisal Specialist Hospital and Research Center in Riyadh, where she leads advanced research projects in cancer biology and immunology. Prior to this, she was a Post-doctoral Fellow (2020–2023), focusing on cancer and inflammatory disease mechanisms. Dr. Al-Ahmadi’s experience includes roles as a Research Assistant (2007–2015) and a Research Technician (2002–2006), where she was deeply involved in cancer research and molecular biology assays. She has also mentored Ph.D., master’s, and undergraduate students throughout her career. Her research has had significant impact both in clinical settings and in experimental fields, including innovative studies aboard the ISS in 2023, demonstrating her versatility in different research environments.

Research Focus

Dr. Wijdan Al-Ahmadi’s research is focused on understanding the underlying mechanisms of diseases, particularly cancer, inflammatory disorders, and cardiovascular diseases. She is dedicated to uncovering how specific genetic mutations and signaling pathways contribute to disease progression, aiming to identify novel therapeutic targets for better patient outcomes. Dr. Al-Ahmadi’s work in space science is also notable, having contributed to microgravity research aboard the ISS, exploring how human physiology and disease processes respond in space. Her findings not only have applications for space health but also provide critical insights that can benefit human health on Earth. She is driven by the potential of personalized medicine and therapeutic interventions that address the root causes of disease.

Publication Top Notes

  1. Pro-atherogenic actions of signal transducer and activator of transcription 1 serine 727 phosphorylation in LDL receptor deficient mice via modulation of plaque inflammation. 🧬🔬
  2. Protective effects of a unique combination of nutritionally active ingredients on risk factors and gene expression associated with atherosclerosis in C57BL/6J mice fed a high-fat diet. 🥗🧪
  3. Posttranscriptional control of the chemokine receptor CXCR4 expression in cancer cells. 🧑‍🔬🦠
  4. miR-29a inhibition normalizes HuR over-expression and aberrant AU-rich mRNA stability in invasive cancer. 🧬💡
  5. The RNA-binding zinc-finger protein tristetraprolin regulates AU-rich mRNAs involved in breast cancer-related processes. 🔬💥
  6. Alternative polyadenylation variants of the RNA binding protein, HuR: abundance, role of AU-rich elements and auto-Regulation. 🧬📊
  7. Cloning-free regulated monitoring of reporter and gene expression. 🧬🧑‍🔬
  8. RNase L downmodulation of the RNA-binding protein, HuR, and cellular growth. 🔬🧑‍🔬
  9. Bioinformatics and experimental derivation of an efficient hybrid 3′ untranslated region and use in expression active linear DNA with minimum poly(A) region. 💻🧬
  10. Expedient liquid chromatographic method with fluorescence detection for montelukast sodium in micro-samples of plasma. 🧪💉

 

 

 

Atherosclerosis, coronary artery disease | Best Researcher Award

Published on by Popular EngineerLeave a Comment on Atherosclerosis, coronary artery disease | Best Researcher Award

Mrs. Agnė Liuizė | Atherosclerosis, coronary artery disease | Best Researcher Award

PhD student, cardiologist, Department of Biochemistry, Lithuanian University of Health Sciences, Kaunas, Lithuania.

Agnė Liuizė (Abramaviciute) is a cardiologist and PhD student at the Lithuanian University of Health Sciences, Kaunas, Lithuania. She completed her Master’s degree in Medicine and obtained her medical doctor qualification in 2017. In 2021, she achieved professional cardiologist qualifications and passed the European General Examination in Cardiology. Agnė is currently pursuing PhD studies in the Department of Biochemistry, focusing on the molecular mechanisms underlying atherosclerosis. Alongside her academic work, she practices cardiology at Kaunas Clinics, contributing to both clinical care and research. Agnė has authored six scientific publications and is passionate about advancing cardiovascular medicine, particularly in understanding the complex biochemical factors influencing cardiovascular diseases. She aims to improve patient outcomes through her research on oxidative stress, inflammation, and endothelial damage.

Education

Agnė Liuizė graduated from the Lithuanian University of Health Sciences Hospital in 2017 with a Master’s degree in Medicine, which also qualified her as a medical doctor. She obtained her professional cardiologist qualification in 2021 after completing residency training. During this time, she also passed the European General Examination in Cardiology, marking a significant milestone in her academic and clinical journey. In October 2023, Agnė began her PhD studies at the Department of Biochemistry, Lithuanian University of Health Sciences. Her research focuses on exploring the role of cellular matrix proteins, cytokines, and oxidative stress in cardiovascular disease development, particularly atherosclerosis. Agnė has always demonstrated a strong commitment to advancing her knowledge in both clinical practice and scientific research, ensuring a balanced approach to her academic and medical career.

Experience

Agnė Liuizė’s clinical career began in 2021 when she obtained her professional cardiologist qualification. From September to December 2021, she worked as a cardiologist at Kaunas Hospital, Lithuanian University of Health Sciences Hospital. Since January 2022, she has been employed as a cardiologist at the Kaunas Clinics, Lithuanian University of Health Sciences Hospital. Her clinical experience has allowed her to apply her medical knowledge to diagnosing and treating cardiovascular diseases while collaborating closely with multidisciplinary teams. In parallel with her clinical work, Agnė has focused on her PhD studies in the Department of Biochemistry, further enhancing her expertise in cardiovascular research. Her academic experience, combined with hands-on clinical practice, allows Agnė to contribute significantly to both patient care and scientific advancements in the field of cardiology. She continues to make an impact in both the clinic and the laboratory through her research on atherosclerosis.

Research Focus

Agnė Liuizė’s research focuses on the molecular mechanisms involved in the development of atherosclerosis. Specifically, her PhD project examines the role of cellular matrix proteins, including thrombospondins, which are involved in tissue remodeling and fibrosis. She investigates the inflammatory markers and cytokines, such as GDF-15, TNF-alpha, and TGF-beta, which play key roles in cardiovascular diseases. Additionally, Agnė explores endothelial damage markers like endocan and vimentin, which are important for understanding vascular injury. Her research also delves into oxidative stress, measuring markers like protein carbonyls, oxidized lipoproteins, and paraoxonase-1 (POX-1), which contribute to the pathological processes in atherosclerosis. By investigating these molecular markers, Agnė aims to identify potential therapeutic targets for improving cardiovascular health and preventing atherosclerosis-related complications. Her research is not only relevant to understanding disease mechanisms but also critical in advancing diagnostic and therapeutic strategies for cardiovascular patients.

Publications:

  1. TGF-β Isoforms and GDF-15 in the Development and Progression of Atherosclerosis 📖
  2. Novel Knowledge about Molecular Mechanisms of Heparin-Induced Thrombocytopenia Type II and Treatment Targets 💉
  3. Relationship between Oxidative Stress and Left Ventricle Markers in Patients with Chronic Heart Failure 💔

Funda Başyiğit | Cardiology | Best Researcher Award

Published on by Popular EngineerLeave a Comment on Funda Başyiğit | Cardiology | Best Researcher Award

Assoc Prof Dr Funda Başyiğit | Cardiology | Best Researcher Award

Cardiology at Ankara Etlik City Hospital in Turkey

Dr. Fikret Başyiğit is an esteemed cardiologist with over 22 years of experience in diagnosing and treating cardiovascular conditions. He specializes in interventional cardiology with a proven track record of advanced interventional procedures. His expertise spans preventive cardiology, echocardiography, and invasive cardiology, offering comprehensive patient care. Currently an Associate Professor at Ankara Etlik City Hospital, he has held various consultant positions across prominent hospitals in Turkey. Dr. Başyiğit is also an active researcher and has published numerous influential papers on topics like myocardial infarction and coronary artery disease. He is dedicated to staying at the forefront of cardiology research and innovations, aiming to advance both clinical practices and patient outcomes.

Profile

Strengths for the Award

  • Extensive Experience: With over two decades of experience in cardiology, including expertise in preventive and invasive cardiology, the candidate has demonstrated a broad range of skills in the field.
  • High Publication Volume: The individual has co-authored numerous peer-reviewed articles in reputable journals, focusing on various aspects of cardiology such as myocardial infarction, coronary artery disease, and advanced cardiac imaging techniques.
  • Cutting-edge Research: Their work on serum pleiotrophin levels, thrombus burden, and the predictive value of novel scores for cardiac conditions showcases a commitment to advancing medical knowledge.
  • Collaborative Projects: The person has collaborated with a diverse group of specialists, which adds credibility to their ability to work within multidisciplinary teams—vital for research development.
  • Academic Leadership: The current role as an Associate Professor and experience in leading complex interventional procedures suggest both academic and practical expertise.

Areas for Improvement

  • Citations and Impact: Although there are citations associated with the individual’s work, increasing the impact factor of their research and gaining more citations could strengthen their case for awards.
  • Further Innovation: Expanding the scope of research beyond current themes to include more innovative or emerging topics within cardiology, such as AI integration or personalized medicine, could enhance the overall research impact.

Education 

Dr. Fikret Başyiğit earned his undergraduate degree in Medicine from Hacettepe University’s Faculty of Medicine (English) between September 1996 and June 2002. Following this, he pursued specialized postgraduate training at Yüksek İhtisas Training and Research Hospital, focusing on cardiology from October 2002 to March 2008. His in-depth education and training have equipped him with comprehensive knowledge in cardiovascular health, diagnostics, and therapeutic interventions. This robust academic foundation has paved the way for his clinical success and contributions to cardiology, especially in invasive cardiology and myocardial research. With ongoing dedication to learning and advancement, Dr. Başyiğit continually integrates the latest developments in the field into his practice, ensuring the highest standard of patient care and clinical outcomes.

Research Focus 

Dr. Fikret Başyiğit’s research is primarily centered on cardiovascular disease, myocardial infarction, and coronary artery disease. His work delves into the relationship between biomarkers like serum pleiotrophin levels and clinical outcomes in patients with non-ST-segment elevation myocardial infarction. Additionally, he explores advanced diagnostic tools like echocardiography and the predictive value of various scoring systems in determining thrombus burden. Another focus area is preventive cardiology, examining factors like neutrophil to HDL-C ratios and their association with coronary artery stenosis. Dr. Başyiğit has also contributed research on innovative imaging techniques for mitral annulus perforation and the effects of implantable cardioverter defibrillators. His research not only advances understanding but also informs better clinical strategies to improve cardiovascular health outcomes.

Publication

  • 📝 The Relationship Between SYNTAX II Score and Serum Pleiotrophin Level in Patients with Non-ST-Segment Elevation Myocardial Infarction (2023)
  • 📝 3-Dimensional Images of Mitral Annulus Perforation: An Alien’s Mouth (2022)
  • 📝 The Predictive Value of MAPH Score for Determining Thrombus Burden in Patients with Non-ST Segment Elevation Myocardial Infarction (2022)
  • 📝 Association of Serum Pleiotrophin Levels with Acute Coronary Syndrome (2022)
  • 📝 The Role of Serum Resolvin D1 Levels in Determining the Presence and Prognosis of ST-Segment Elevation Myocardial Infarction (2022)
  • 📝 Relationship Between the Neutrophil to HDL-C Ratio and Anatomical Significance of Coronary Artery Stenosis in Patients with Documented Myocardial Ischemia (2022)
  • 📝 Effect of Implantable Cardioverter Defibrillator Implantation on Frontal QRS-T Angle (2022)
  • 📝 Serum Thiol Levels and Thiol/Disulfide Homeostasis in Patients with Rheumatic Mitral Valve Disease and Healthy Subjects (2021)
  • 📝 Can Hemodialysis Change QRS Axis in Patients Without Cardiovascular Disease? (2018)
  • 📝 Combination of Change in Hematological Parameters with Exercise Stress Test to Predict Coronary Artery Disease (2018)

Conclusion

The individual is a highly qualified and experienced cardiologist with a rich research background, making them a strong candidate for the “Best Researcher Award.” While additional citations and innovation would further solidify their standing, the depth of their work in cardiovascular research, combined with their professional roles, firmly supports their suitability for this recognition.